相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Competitive but Not Allosteric mTOR Kinase Inhibition Enhances Tumor Cell Radiosensitivity
Thomas J. Hayman et al.
TRANSLATIONAL ONCOLOGY (2013)
Translation Initiation Factor eIF4E Is a Target for Tumor Cell Radiosensitization
Thomas J. Hayman et al.
CANCER RESEARCH (2012)
mTOR Signaling in Growth Control and Disease
Mathieu Laplante et al.
CELL (2012)
The translational landscape of mTOR signalling steers cancer initiation and metastasis
Andrew C. Hsieh et al.
NATURE (2012)
PI3K and mTOR Signaling Pathways in Cancer: New Data on Targeted Therapies
Lise Willems et al.
CURRENT ONCOLOGY REPORTS (2012)
The Brain Microenvironment Preferentially Enhances the Radioresistance of CD133+ Glioblastoma Stem-like Cells
Muhammad Jamal et al.
NEOPLASIA (2012)
Rapamycin passes the torch: a new generation of mTOR inhibitors
Don Benjamin et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Genetic Dissection of the Oncogenic mTOR Pathway Reveals Druggable Addiction to Translational Control via 4EBP-eIF4E
Andrew C. Hsieh et al.
CANCER CELL (2010)
AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive Mammalian Target of Rapamycin Kinase Inhibitor with In vitro and In vivo Antitumor Activity
Christine M. Chresta et al.
CANCER RESEARCH (2010)
Beyond Rapalog Therapy: Preclinical Pharmacology and Antitumor Activity of WYE-125132, an ATP-Competitive and Specific Inhibitor of mTORC1 and mTORC2
Ker Yu et al.
CANCER RESEARCH (2010)
γH2AX foci analysis for monitoring DNA double-strand break repair Strengths, limitations and optimization
Markus Loebrich et al.
CELL CYCLE (2010)
Microenvironmental Regulation of Glioblastoma Radioresponse
Muhammad Jamal et al.
CLINICAL CANCER RESEARCH (2010)
Targeting Eukaryotic Translation Initiation Factor 4E (eIF4E) in Cancer
Andrew C. Hsieh et al.
CLINICAL CANCER RESEARCH (2010)
mTOR signaling in glioblastoma: lessons learned from bench to bedside
David Akhavan et al.
NEURO-ONCOLOGY (2010)
Regulation of Translation Initiation in Eukaryotes: Mechanisms and Biological Targets
Nahum Sonenberg et al.
CELL (2009)
Not all substrates are treated equally Implications for mTOR, rapamycin-resistance and cancer therapy
Andrew Y. Choo et al.
CELL CYCLE (2009)
SSEA-1 Is an Enrichment Marker for Tumor-Initiating Cells in Human Glioblastoma
Myung Jin Son et al.
CELL STEM CELL (2009)
CD133+ Glioblastoma Stem-like Cells are Radiosensitive with a Defective DNA Damage Response Compared with Established Cell Lines
Amy M. McCord et al.
CLINICAL CANCER RESEARCH (2009)
An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1
Carson C. Thoreen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Physiologic Oxygen Concentration Enhances the Stem-Like Properties of CD133+ Human Glioblastoma Cells In vitro
Amy M. McCord et al.
MOLECULAR CANCER RESEARCH (2009)
Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2
Morris E. Feldman et al.
PLOS BIOLOGY (2009)
Laminin enhances the growth of human neural stem cells in defined culture media
Peter E. Hall et al.
BMC NEUROSCIENCE (2008)
Radiation-induced gene translation profiles reveal tumor type and cancer-specific components
Sandhya Kumaraswamy et al.
CANCER RESEARCH (2008)
Antitumor activity of rapamycin in a phase I trial for patients with recurrent PTEN-Deficient glioblastoma
Tim F. Cloughesy et al.
PLOS MEDICINE (2008)
Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: Role of autophagic, cell death
Hong Jiang et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
CD133+ and CD133- glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles
Dagmar Beier et al.
CANCER RESEARCH (2007)
Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines
Jeongwu Lee et al.
CANCER CELL (2006)
Targeting the Akt/mammalian target of rapamycin pathway for radiosensitization of breast cancer
Jeffrey M. Albert et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Radiation-induced changes in gene expression involve recruitment of existing messenger RNAs to and away from polysomes.
X Lü et al.
CANCER RESEARCH (2006)
Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: A north central cancer treatment group study
E Galanis et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The mTOR inhibitor RAD001 sensitizes tumor cells to DNA-damaged induced apoptosis through inhibition of p21 translation
I Beuvink et al.
CELL (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma
R Galli et al.
CANCER RESEARCH (2004)
Identification of human brain tumour initiating cells
SK Singh et al.
NATURE (2004)
mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E
DC Fingar et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas
A Chakravarti et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Radiation sensitivity, H2AX phosphorylation, and kinetics of repair of DNA strand breaks in irradiated cervical cancer cell lines
JP Banáth et al.
CANCER RESEARCH (2004)
Two molecularly distinct G2/M checkpoints are induced by ionizing irradiation
B Xu et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Involvement of Brca1 in S-phase and G2-phase checkpoints after ionizing irradiation
B Xu et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
分享论文
